« Back
Home /
SGC-CBP30

SGC-CBP30

Item no.	CS-2096-10mg
Manufacturer	ChemScene
Amount	10mg
Category	Oncology By Cell Type Carcinoma Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Similar products	1613695-14-9
Available
CAS	1613695-14-9
Purity	>98%
Formula	C28H33ClN4O3
MWt	509.04
Solubility	DMSO : >= 31 mg/mL (60.90 mM)
Clinical Information	No Development Reported
Pathway	Epigenetics; Epigenetics
Target	Epigenetic Reader Domain; Histone Acetyltransferase
Biological Activity	SGC-CBP30 is a potent CREBBP/EP300 bromodomain inhibitor with IC50 of 21-69 and 38 nM for CREBBP and EP300 bromodomains, respectively. IC50 Value: 21-69 nM(for CREBBP); 38 nM(for EP300) Target: Others in vivo: SGC-CBP30 is a highly potent and selective p300/CBP bromodomain inhibitor (IC50 ca.0.021-0.069 uM for CBP and ca.0.038 uM for p300). It has 40-fold selectivity for CBP over BRD4. It accelerated FRAP recovery at 1 uM. in vivo: N/A

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

CS-2096-10mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 10mg

available

Delivery expected until 10/2/2025

Express Delivery: Save 6 days

Compare

Add to wishlist

Get an offer